← Back

Business and Innovation News

Monday, 03 July 2023

INBRAIN Neuroelectronics named by investors as one of the medical device startups to watch in 2023

by Virginia Greco

The fast-growing spin-off of ICN2, IMB-CNM-CSIC and ICREA has attracted the attention of venture capital companies.

Sifted.eu, the leading news and media brand for the European startup community, asked to investors from venture capital companies such as MIG Capital, SHS Capital, Sofinnova Partners and AlbionVC to let readers know which medical device start-ups that they didn´t have in their portfolio they considered as interesting. Among the 11 start-ups selected as the most promising and definitely worth keeping an eye on in the second half of 2023 is INBRAIN Neuroelectronics.

INBRAIN Neuroelectronics, S.L., a spin-off company founded by researchers from the Catalan Institute of Nanoscience and Nanotechnology (ICN2), the Institute of Microelectronics of Barcelona (IMB-CNM-CSIC) and ICREA, is a medical device company dedicated to the development and commercialization of graphene-based neural interfaces and an intelligent decoding and neuromodulation platform. Their advanced devices can decode and modulate the neural network with high resolution and collect data, eventually leading to a close-loop solution for patients with central nervous system diseases such as Parkinson’s Disease.